Andere talen ADMA Biologics, Inc.

Aandelen

ADMA

US0008991046

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 15-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,98 ^USD	-0,66%		-3,86%	+32,30%

02/04	ADMA Biologics, Inc. Kondigt de promotie aan van Kaitlin Kestenberg tot Chief Operating Officer	CI
26/03	ADMA BIOLOGICS, INC. : HC Wainwright ontvangt een koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer	02/04
Adma Biologics Insider Sold Shares Worth $2,803,741, According to a Recent SEC Filing	20/03
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®	11/03
Adma Biologics, Inc. Announces FDA Approvals of Extended Room Temperature Storage Conditions for Asceniv & Bivigam	11/03
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference	05/03
ADMA Biologics Q4 Net Loss Widens, Revenue Rises; Increases 2024, 2025 Revenue Outlook; Seeks Successor for Chief Financial Officer	29/02
Adma Biologics: Q4 Earnings Snapshot	28/02
ADMA Biologics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Earnings Flash (ADMA) ADMA BIOLOGICS Posts Q4 Revenue $73.9M, vs. Street Est of $73M	28/02
ADMA Biologics, Inc. Revises Financial Guidance for the Years 2024 and 2025	28/02
ADMA Biologics Announces CFO Transition	28/02
ADMA Biologics Announces CFO Transition	28/02
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	28/02
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	28/02
ADMA Biologics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	21/02
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	21/02
ADMA Biologics Implements ADMAlytics AI Program to Bolster Production	21/02
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics	21/02
ADMA Biologics, Inc Successfully Implements Innovative AI Program, Named ADMAlytics	21/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen ADMA Biologics, Inc.

Aandelen

ADMA

US0008991046

Andere talen

Filters